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Candida glabrata is considered a major opportunistic fungal pathogen of humans.
The capacity of this yeast species to cause infections is dependent on the ability
to grow within the human host environment and to assimilate the carbon sources
available. Previous studies have suggested that C. albicans can encounter glucose-
poor microenvironments during infection and that the ability to use alternative non-
fermentable carbon sources, such as carboxylic acids, contributes to the virulence of
this fungus. Transcriptional studies on C. glabrata cells identified a similar response,
upon nutrient deprivation. In this work, we aimed at analyzing biofilm formation,
antifungal drug resistance, and phagocytosis of C. glabrata cells grown in the presence
of acetic acid as an alternative carbon source. C. glabrata planktonic cells grown in
media containing acetic acid were more susceptible to fluconazole and were better
phagocytosed and killed by macrophages than when compared to media lacking acetic
acid. Growth in acetic acid also affected the ability of C. glabrata to form biofilms.
The genes ADY2a, ADY2b, FPS1, FPS2, and ATO3, encoding putative carboxylate
transporters, were upregulated in C. glabrata planktonic and biofilm cells in the presence
of acetic acid. Phagocytosis assays with fps1 and ady2a mutant strains suggested a
potential role of FPS1 and ADY2a in the phagocytosis process. These results highlight
how acidic pH niches, associated with the presence of acetic acid, can impact in the
treatment of C. glabrata infections, in particular in vaginal candidiasis.
Keywords: Candida glabrata, acetate, transporters, phagocytosis, antifungal drug resistance, fluconazole,
candidiasis
Introduction
Candida glabrata is a prevalent human fungal pathogen that has become the second most frequent
cause of candidiasis after Candida albicans in the United States, according to the SENTRY
Program (Pfaller et al., 2001, 2011). Both species are commensal colonizers of mucosal surfaces.
However, they are also successful opportunistic pathogens, causing either superﬁcial or life-
threatening disseminated infections reaching mortalities of around 40%. C. glabrata infections are
especially diﬃcult to treat due to a high inherent antifungal resistance, particularly against azoles
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(Pfaller, 2012). Moreover,C. glabrata colonizes host tissues as well
as abiotic surfaces as bioﬁlms (Silva et al., 2009). The formation
of Candida bioﬁlms raises important clinical issues because of
a signiﬁcant further increase in antifungal drug resistance as
well as evasion of host immune defenses. Additionally, bioﬁlm
formation on medical devices can cause the failure of the device
and can serve as a reservoir or source for future continuing
infections (Douglas, 2003; Ramage et al., 2005; Calderone and
Clancy, 2012).
Recently, it has been shown that C. albicans growth on
an alternative carbon source, such as lactate, can aﬀect stress
adaptation, antifungal drug resistance, the cell wall architecture
and proteome including immune detection (Ene et al., 2012a,b,
2013). Lactate-grown cells were taken up by macrophages less
eﬃciently, but they were more eﬃcient at killing and escaping
phagocytosis (Ene et al., 2013). Of note,C. glabrata cells also resist
killing by macrophages and have evolved distinct strategies for
intracellular survival (Otto and Howard, 1976; Kaur et al., 2007;
Seider et al., 2010). However, in these studiesC. glabrata cells were
grown in glucose. In the case of C. albicans, evidence exists that
growth in the presence of an alternative carbon sources aﬀects
phagocytosis (Ene et al., 2013).
Adaptation to the host environment is essential for Candida
spp. to infect and survive in various anatomical sites of the
human host, some of which are clearly glucose-limited (Han
et al., 2011). When C. albicans cells face a glucose-poor niche
their metabolism changes. For instance, after phagocytosis of
C. albicans by macrophages, repression of glycolysis occurs, the
glyoxylate cycle, gluconeogenesis, and β-oxidation (Fradin et al.,
2003, 2005; Prigneau et al., 2003; Lorenz et al., 2004; Barelle
et al., 2006; Wilson et al., 2009) are induced. Additionally, data
obtained with mutant strains in these pathways using mouse
models of systemic candidiasis showed that the glyoxylate cycle is
required for virulence (Lorenz and Fink, 2001, 2002; Barelle et al.,
2006; Han et al., 2011), while β-oxidation is not (Piekarska et al.,
2006). Thereby, it was postulated that acetyl-CoA feeding into
the glyoxylate cycle might be derived from other non-fermentable
carbon sources, such as lactate or acetate (Piekarska et al., 2006;
Ramirez and Lorenz, 2007). This hypothesis was supported by
the apparent expression regulation of two C. albicans carboxylic
acids transporter genes, JEN1 and JEN2, following macrophages
internalization. JEN1 encodes a monocarboxylic acid transporter
(Soares-Silva et al., 2004) and JEN2 a dicarboxylic acid permease
(Vieira et al., 2010).
In C. glabrata, lactate assimilation is at least required for
the survival in the intestine (Ueno et al., 2011). However, JEN1
homologues are absent from the C. glabrata genome (Lodi
et al., 2007). A transcription proﬁle of C. glabrata following
macrophage internalization revealed the up-regulation of genes
involved in gluconeogenesis, β-oxidation and glyoxylate cycle,
similar to what has been described for C. albicans. Moreover,
a putative acetate transporter (ADY2a) appears to be induced
(Kaur et al., 2007). The induction of ADY2a was also observed
when C. glabrata is facing neutrophils (Fukuda et al., 2013),
implying that in this environment, C. glabrata may assimilate
acetate and other short-chain carboxylic acids for use as an
alternative carbon source. Another observation supporting this
hypothesis is that Fps1, a homologue of a Saccharomyces
cerevisiae acetate channel, is also upregulated inside macrophages
(Seider et al., 2010).
In S. cerevisiae, ADY2 (also called ATO1) encodes a permease-
mediating uptake of acetate–propionate–formate present in
ethanol or acetate-grown cells (Casal et al., 1996; Paiva
et al., 2004; Pacheco et al., 2012). In conjunction with its
two additional homologues, ATO2 and ATO3, it has also
been implicated in ammonia export (Palkova et al., 2002;
Vachova et al., 2009). Besides Ady2, Fps1 is a channel
promoting the facilitated diﬀusion of undissociated acetic acid
(CH3COOH) at low pH in S. cerevisiae (Mollapour and
Piper, 2007). The C. glabrata genome encodes two putative
homologues of ScADY2 and one of ScATO3, all of which remain
functionally uncharacterized. These C. glabrata homologues
are CAGL0M03465g (designated ADY2a) and CAGL0L07766g
(designated ADY2b), sharing 74 and 73% identity with ScADY2,
respectively, and CAGL0A03212g (designated ATO3), sharing
62% identity with ScATO3. At least twoC. glabrata homologues of
ScFps1 have been described: CAGL0C03267g (designated FPS1)
and CAGL0E03894g (designated FPS2; Beese-Sims et al., 2012).
These genes may act as glycerol channels, as the double mutant
fps1 fps2 accumulates glycerol, displays constitutive cell wall stress
and hypersensitivity to treatment by caspofungin (Beese-Sims
et al., 2012).
The aim of this study was to uncover how host
microenvironments, and in particular, acidic niches that contain
acetic acid, alter C. glabrata pathogenicity and susceptibility to
antifungals. We have characterized acetic acid-grown planktonic
and bioﬁlm cells with respect to their antifungal drug resistance,
as well as their interaction with macrophages. We examined
growth at pH 5.0, a value above the pKa of the acid, where the
charged anionic form (CH3COO−) acts as a nutrient rather
than the undissociated acid (CH3COOH) conferring a weak acid
stress (Casal et al., 2008; Stratford et al., 2013). Elucidating the
eﬀect of local nutrients and pH environment on drug resistance
and phagocytosis can potentially provide new and eﬀective
treatment strategies for C. glabrata infections such as vaginal
candidiasis.
Materials and Methods
Yeast Strains and Growth Conditions
Candida glabrata strains used in this work are listed in Table 1.
Gene deletion was performed in the ATCC2001 background,
500 bp long homology ﬂanking regions were ampliﬁed from
genomic DNA, adding ApaI/XhoI RE sites, for the 5′ fragment,
and SacI/SacII RE sites, for the 3′ fragment, and ligated
into plasmid pSFS2 (Reuss et al., 2004). HTL strain was
constructed from the ATCC2001 background, through the
deletion of HIS3, LEU2, TRP1, using the SAT1 ﬂipper method
(Shen et al., 2005), and transformed by electroporation into
C. glabrata ATCC2001 strain, as described elsewhere (Reuss
et al., 2004). For construction of CgFPS1 (CAGL0C03267g) and
CgADY2a (CAGLOMO3465g) genomic deletion cassettes, the
nourseothricin marker gene, NAT1 was ampliﬁed from plasmid
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TABLE 1 | Candida glabrata strains used in this study.
C. glabrata strains Genotype Reference
ATCC2001 (CBS138) Wild type ATCC collection
(available at www.atcc.
org)
HTL Derived from ATCC2001,
his3::FRT, leu2::FRT and
trp1::FRT
Jacobsen et al. (2010)
ady2a
(CAGL0M03465g)
Derived from HTL,
ady2a::NAT1
Schwarzmuller et al.
(2014)
fps1 (CAGL0C03267g) Derived from HTL,
fps1::NAT1
Schwarzmuller et al.
(2014)
pJK863 (Shen et al., 2005), using primers fp_NAT1_U2 and
rp_NAT1_D2. Barcodes and overlap sequences were added to the
marker fragment and used to construct the disruption cassettes,
by fusion PCR, as described previously (Noble and Johnson,
2005).
The cultures were maintained on plates of YPD: yeast extract
(1%, w/v), peptone (1%, w/v), glucose (2%, w/v) and agar (2%,
w/v). For growth phenotypes yeast cells were grown at 30, 37, and
42◦C during 96 h in synthetic complete (SC) media (prepared
with 0.67% (w/v) Difco yeast nitrogen base mineral medium
without amino acids plus 2 g/l complete amino acid mixture)
with: glucose (2% w/v), lactic acid (0.5% v/v; pH 5.0), acetic acid
(0.5% v/v; pH 5.0 or pH 6.0), citric acid (1%, w/v; pH 5.0) malic
acid (1% w/v; pH 5.0), pyruvic acid (1% w/v), and succinic acid
(1% w/v; pH 5.0), as sole carbon and energy sources and 2% (w/v)
agar.
Minimal Inhibitory Concentration (MIC)
Determination
The MIC assays were performed by the microdilution method
according to the Clinical and Laboratory Standards Institute
(CLSI, 2008) document M27-A3, with some modiﬁcations, using
RPMI 1640 broth, supplemented with 0.165 M of MOPS, with
or without adding 0.5% acetic acid at pH 5.0 (Pfaller et al.,
2008). Diﬀerent concentrations of ﬂuconazole ranging from 0
to 1250 μg/ml were used. The MIC of the antifungal agents
against each C. glabrata strain was determined visually and
by total number of colony forming units (CFUs). For this
purpose each condition was serially diluted in 1× phosphate
buﬀered saline (PBS) and 10 μl of cell suspensions of each
dilution were plated in YPD medium. All the experiments
were performed in triplicate, at least in three independent
assays.
Biofilm Formation and Antifungal Susceptibility
Bioﬁlm formation was performed as described previously by Silva
et al. (2009). Brieﬂy, 200 μl of 1 × 105 cells/ml suspensions in
RPMI 1640 with or without 0.5% (v/v) acetic acid at pH 5.0
were placed into 96-wells polystyrene microtiter plates (Orange
Scientiﬁc, Braine-l′Alleud, Belgium) and incubated at 37◦C with
gentle agitation. After 24 h, the entire medium was replaced
by 200 μl of fresh medium. To study the eﬀect of ﬂuconazole
on bioﬁlm formation, diﬀerent concentrations of ﬂuconazole
(312.5 and 1250 μg/ml) were prepared in RPMI 1640 medium
(Sigma, St. Louis, MO, USA) and added to the 24-h old pre-
formed bioﬁlms. The microtiter plates were incubated for an
additional 24 h.
Biofilm Characterization
Biofilm Biomass Quantification
Total bioﬁlm biomass was quantiﬁed by crystal violet (CV)
staining (Silva et al., 2009). The culture medium was removed
by aspiration and the bioﬁlm washed once with 200 μl of PBS
to remove non-adherent cells. The bioﬁlms were ﬁxed with
200 μl of methanol for 15 min. The microtiter plates were
allowed to dry at room temperature, and 200 μl of CV (1%
v/v) were added to each well and incubated for 5 min. The
wells were then gently washed twice with water, followed by
addition of 200 μl acetic acid (33%, v/v) to release and dissolve
the stain. The absorbance was determined in a microtiter plate
reader (Bio-Tek Synergy HT, Izasa) at 570 nm. The results
are presented as percentage of biomass reduction. Experiments
were performed at least three times using independent biological
samples.
Biofilm Viability Quantification
The number of cultivable cells in bioﬁlms was determined by
the enumeration of CFUs counts. For that, the medium was
aspirated and the bioﬁlms washed once with PBS to remove
non-adherent cells. Next, bioﬁlms were scraped from wells
and the suspensions were vigorously vortex-mixing for 2 min
to disaggregate cells from matrix. Serial 10-fold dilutions in
PBS were plated onto YPD plates and incubated for 24 h
at 37◦C. The results were presented as percentage of CFU
reduction (log scale). The complete bioﬁlm dispersal was
conﬁrmed by CV staining. Experiments were performed in
duplicate and at least three times using independent biological
samples.
Biofilm Structure
Bioﬁlm structure was assessed by scanning electron microscopy
(SEM). Bioﬁlms were allowed to form in 24-wells polystyrene
microtiter plates (Orange Scientiﬁc, Braine-l′Alleud, Belgium),
each well containing 1 ml of 1 × 105 cells/ml suspensions, as
described previously. After 48 h of formation, bioﬁlms were
washed with PBS and dehydrated with alcohol (using 70%, v/v
ethanol for 10 min, 90%, v/v ethanol for 10 min, and 100%, v/v
ethanol for 20 min) and then air-dried. Prior to inspection, the
base of the wells were mounted onto aluminium stubs, sputter
coated with gold and observed with an S-360 scanning electron
microscope (Leo, Cambridge, MA, USA).
Gene Expression Analysis
Bioﬁlms were grown as described above. After their formation,
the medium was aspirated and the wells washed with PBS to
remove the non-adherent cells. Bioﬁlms were then scraped from
wells and sonicated (Ultrasonic Processor, Cole-Parmer) for 30 s
at 30 W. Cells were harvested by centrifugation at 8000 g for
5 min at 4◦C. Additionally, planktonic cells, cells were grown in
25 ml of RPMI 1640 with or without 0.5% v/v acetic acid at pH
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5.0 and in the absence or in the presence of 50 μg/ml ﬂuconazole
for 48 h at 37◦C.
For total RNA isolation and puriﬁcation, we used the
E.Z.N.A. R© Total RNA Kit, Omega Bio-tek R© according
to the manufacturer’s instructions. To remove residual
DNA contaminations, samples were treated with DNase I
(InvitrogenTM), according to the manufacturer’s instructions.
Purity and concentration of total RNA was evaluated using a
NanoDrop spectrophotometer. To synthesize the cDNA the
High-Capacity cDNA Reverse Transcription Kit (InvitrogenTM)
was used according to the manufacturer’s instructions.
Quantitative Real-time PCR
Relative quantitative RT-PCR of the cDNA samples was carried
out in a CF X96 Real-Time PCR System from Bio-Rad
Laboratories using Power SYBR R© Green PCR Master Mix
(Applied Biosystems R©). The primers used to amplify the selected
genes using qPCR were designed using Primer Blast (Rozen and
Skaletsky, 2000; Ye et al., 2012) and are listed in Table 2. The
reaction mixture was set up in a total volume of 20 μl using 10 μl
of SYBR R© Green PCR Master Mix, 0.3 μM of each primer and
4 μl of cDNA (diluted 1:20) and nuclease-free water. Thermo
cycling conditions for qPCR were 10 min at 95◦C, followed
by 40 cycles of 95◦C for 15 s, the correspondent annealing
temperature for each primer for 1 min (Supplementary Table
S1), and 65◦C for 5 s. A negative control without template was
conducted for each gene in each PCR run, and a control for
DNA contamination was implemented by using the puriﬁed
RNA samples as template. The housekeeping gene, PGK1 (Li
et al., 2012) was used to normalize the gene expression. The
relative quantiﬁcation of gene expression was performed by the
CT method (Livak and Schmittgen, 2001). Experiments were
performed in two independent biological samples.
Phagocytosis Assays
The murine macrophage-like cell line J774A.1 was cultured in
complete Dulbecco’s modiﬁed eagle’s medium (DMEM) at 37◦C
in a 5% CO2 atmosphere. DMEM was supplemented with 10%
heat-inactivated fetal bovine serum (FBS) (Valbiotech), 2 mM
TABLE 2 | List of primers used in this study.
Target gene Primer Sequence (5′→3′ ) PCR
product
size (bp)
CAGL0C03267g FPS1 fwd
FPS1 rev
CATGTCTACCGCTGCTGCTA
AGTGGCCTAGGTTCAACACG
113
CAGL0E03894g FPS2 fwd
FPS2 rev
TGCTAGAAGCCGCAGACAAA
GCCTCCAAGACCGTCGTTAT
88
CAGL0M03465g ADY2a fwd
ADY2a rev
TGTGCTCCTACGGTGGTTTC
GGTCCAGCCCAGTAGGTAGA
131
CAGL0L07766g ADY2b fwd
ADY2b rev
CCCCACCATCGTCTCACAAA
AGCAGCAGGACCGACTACTA
140
CAGL0A03212g ATO3 fwd
ATO3 rev
CGTGAGCAACATACCCCAGT
CAAGGACAGCACAAGGCAAC
93
Housekeeping gene
CAGL0L07722g
PGK1 fwd
PGK1 rev
CAAACGGTGAAAGAAACGAGAA
CCGACACAGTCGTTCAAGAAAG
100
L-glutamine, 1 mM sodium pyruvate, and 10 mM HEPES.
After reaching conﬂuent growth, macrophages were recovered,
washed, resuspended in complete DMEM, and seeded in a 96-
wells plate at 1 × 105 macrophages/well (ﬁnal volume 250 μl)
in triplicates. Cells were then incubated overnight at 37◦C in
a 5% CO2 atmosphere, to allow for macrophage adherence. In
the following day, phagocytic cells were washed two times with
PBS buﬀer to remove non-adherent cells. Yeast cells grown for
48 h at 37◦C in RPMI 1640 medium, with or without 0.5% acetic
acid, were recovered by a brief centrifugation step, and washed
twice in sterile 1× PBS. Yeast suspensions were added to each
well at MOI of 1M:5Y (Macrophage:Yeast cells) at 37 ◦C and 5%
CO2. After co-incubation with macrophages (3 and 18 h), plates
were centrifuged at 1000 g for 2 min and 150 μl of supernatant
was stored at -80 ◦C for subsequent Tumor Necrosis Factor Alfa
(TNF-α) quantiﬁcation. To induce macrophages lysis, 150 μl of
cold H2O with 10% saponin were added to macrophage cultures.
After carefully mixing, serial dilutions were prepared and 10 μl
of the two higher dilutions were plated in quadruplicated in YPD
agar. After 24 h of incubation at 37◦C, the number of viable yeast
cells was determined by CFU-counting. Controls consisting of
yeast cells grown in the same conditions without macrophages
were added. The percentage of yeast cells killing by macrophages
were calculated according to the following equation:
% yeast killing= CFU of control well−CFU of test well
CFU of control well
× 100
Two independent experiments of this assay were performed.
Phagocytosis was also examined bymicroscopy and cytometry
according to a recently described protocol (Carneiro et al.,
2014). Brieﬂy, yeast cells grown for 48 h at 37◦C in RPMI
1640 medium, with or without 0.5% acetic acid, were recovered
by centrifugation and washed twice in sterile PBS. Yeast cells
were incubated for 10 min in formol/ethanol (1:9), to ﬁx cell
wall pathogen-associated molecular patterns (PAMPs); cells were
then washed ﬁve times with PBS for a complete removal of
formol/ethanol. Yeast cells were incubated with Sytox-Green
(Invitrogen) at 1 μM during 10 min, at room temperature in the
dark, washed with PBS, to remove unbound dye, and brought to
the desired cell density in complete DMEM.
Culture of murine macrophage-like cell line J774A.1 was
performed as described above. After reaching conﬂuency,
macrophage cells were recovered, washed, and resuspended in
complete DMEM at a ﬁnal density of 5 × 105 cells/ml. For ﬂow
cytometry, 3 ml of the cell suspension were transferred to a 6-
wells tissue culture plates. For ﬂuorescence microscopy assays,
1 ml cell suspension aliquots were transferred to 24-well culture
plates containing clean sterile glass coverslips (diameter 13 mm).
Macrophage cells were incubated overnight, at 37◦C in a 5% CO2
atmosphere, to allow for macrophage adherence. In the next day,
macrophages cells were washed two times with PBS to remove
non-adherent cells and the adhered cells were used for phagocytic
assays.
Macrophages were incubated with yeast cells suspensions
previously labeled with Sytox-Green at MOI of 1M:5Y for
30 min at 37◦C and 5% CO2. After incubation, plates were
kept on ice to stop phagocytosis, then washed twice with
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complete DMEM to remove unbound yeasts, and ﬁnally
resuspended in 1 ml of the same medium. Macrophages and
adhered yeasts were then incubated with propidium iodide
(Sigma–Aldrich) at a ﬁnal concentration of 120 μg/ml for
5 min at room temperature (Carneiro et al., 2014). Cells
were analyzed by ﬂow cytometry (EPICS XL-MCL, Beckman-
Coulter Corporation) and by ﬂuorescence microscopy (Leica
DM5000B). Results were obtained from two replicates of
each strain/condition. Cytometry results were analyzed using
the Flowing Software Version 2.5.1. These experiments were
performed in duplicates.
Cytokine Quantification
TNF-α production by macrophages infected with C. glabrata
strains was measured using the mouse TNF-α ELISA
ReadySETGo Kit (eBioscience, San Diego, CA, USA),
according to the manufacturer’s instructions. Supernatants
recovered from the CFU assay stored at –80◦C were used
as samples. Macrophages without yeast cells supernatants
were used as a negative control, and macrophages infected
with Escherichia coli cells were used as a positive control
(LPS control). These experiments were performed in
triplicate.
Statistical Analysis
Results were analyzed using GraphPad Prism 5. The statistic tests
used were one-way ANOVA with Turkey multiple comparison
test. All tests were performed with a conﬁdence level of 95%.
Results
Acetic Acid Increases the Susceptibility of
C. glabrata Planktonic Cells to Fluconazole
Candida glabrata ATCC 2001 planktonic cells’ susceptibility to
antifungal drugs was determined by the microdilution method
and conﬁrmed by CFU-counting for two diﬀerent growth
conditions: RPMI and RPMI-containing 0.5% acetic acid, both
at pH 5.0.
In RPMI medium, we obtained a MIC value of 150 μg/mL
for C. glabrata cells and a minimal fungicidal concentration
(MFC) value of 312.5 μg/ml (Table 3). In acetic acid medium,
we obtained lower ﬂuconazole MIC and MFC values (50 and
150 μg/ml, respectively; Table 3). These results show that
acetic acid enhances the susceptibility of C. glabrata cells to
ﬂuconazole.
TABLE 3 | Effect of fluconazole in wild type (WT) C. glabrata ATCC 2001
planktonic cells using two different growth conditions: cells grown in
RPMI pH 5.0 and cells grown in RPMI 0.5% acetic acid pH 5.0.
Condition MIC (µg/ml) MFC (µg/ml)
RPMI pH 5.0 150 312.5
RPMI 0.5% acetic acid pH 5.0 50 150
The minimal inhibitory concentrations (MICs) were determined visually and the
minimal fungicidal concentrations (MFCs) by total number of CFUs.
Candida glabrata Susceptibility to Fluconazole
is Higher in Biofilms than in Planktonic Cells
The experiments described above for C. glabrata planktonic cells
were reproduced for C. glabrata bioﬁlm cells. We compared
C. glabrata bioﬁlms obtained in a media with or without
acetic acid (RPMI vs. RPMI with 0.5% acetic acid, pH 5.0;
Figure 1). In the presence of acetic acid, bioﬁlm biomass as
well as viable cell numbers were reduced, when compared to
RPMI medium only (Figure 1). In both conditions, aggregates
of yeast cells were observed in the bioﬁlms. However, in
the presence of acetic acid these aggregates were smaller
(Figure 1C).
To test the eﬀect of ﬂuconazole, RPMI media with or
without addition of acetic acid at pH 5.0 was used for the
growth of C. glabrata bioﬁlms. After 24 h, ﬂuconazole was
added to the pre-formed bioﬁlms and the total bioﬁlm biomass
and CFUs were evaluated. The presence of ﬂuconazole did
not result in the eradication of the bioﬁlms, in any of the
growth conditions tested. For both conditions, a statistically
signiﬁcant reduction in bioﬁlm biomass and in CFU count was
only obtained with the highest ﬂuconazole concentration of
1250 μg/ml (Figures 1A,B).
Gene Expression Profile in Planktonic and in
Biofilm Cells
The use of acetic acid as a sole carbon and energy source
implies that C. glabrata cells have speciﬁc transporters mediating
acetate uptake. Hence, we assessed by qRT-PCR the expression
proﬁle of C. glabrata putative acetate transporters encoding genes
ADY2a, ADY2b, ATO3, FPS1, and FPS2, both in planktonic
and bioﬁlm cells grown in RPMI with and without acetic
acid.
In the absence of ﬂuconazole, ADY2b, FPS1, FPS2, and ATO3
genes displayed a very weak level of expression in RPMImedium,
both in planktonic and bioﬁlm cells. However, the gene ADY2a
was strongly induced in these conditions (Figures 2A,B). When
cells were grown in the presence of acetic acid, all genes displayed
a higher level of expression, except for FPS2, which was expressed
at low levels. This increase was observed in both planktonic and
bioﬁlm cells (Figures 2A,B) and it was very striking for the
ADY2a gene (p < 0.001 and p < 0.01, respectively).
The eﬀect of the addition of ﬂuconazole in the expression of
the selected genes was also determined. In planktonic cells grown
in RPMI with 50 μg/ml ﬂuconazole, FPS1 expression increased
(p < 0.05) andADY2a expression was maintained, in comparison
with media without the drug. However, when planktonic cells
were grown in the presence of acetic acid with 50 μg/ml
ﬂuconazole, a decrease in ADY2a (p < 0.001) expression was
observed (Figure 2A).
The drug eﬀect was also studied for bioﬁlm cells in the
presence of either 312.5 or 1250 μg/ml ﬂuconazole. The response
of these genes was dependent on the concentration of the drug
and a clear pattern of expression was found: an increase with
312.5 μg/ml of ﬂuconazole and a decrease with the highest drug
concentration (1250 μg/ml). This behavior was identical for cells
grown either in the presence or absence of acetic acid. The
only exception was found for ADY2a, which displayed either a
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FIGURE 1 | Effect of fluconazole in Candida glabrata ATCC2001 pre-formed biofilms. Graph (A) represents the percentage of biomass reduction that
was quantified by crystal violet staining and (B) the percentage of colony-forming units (CFUs) reduction. Two conditions were tested: RPMI pH 5.0 and RPMI
0.5% acetic acid at pH 5.0. Error bars represent SD. ∗ and ∗ ∗ ∗ means that results are statistically significant (p < 0.05) and (p < 0.001), respectively.
(C) Scanning electron microscopy of C. glabrata 48 h formed biofilms grown in RPMI pH 5.0 and RPMI 0.5% acetic acid pH 5.0. The left and right images in
each media represent a magnification of 1000× and 3000×, respectively. Bars in the images correspond to 20 μm in 1000× magnification and 10 μm in
3000× magnification.
maintenance of expression or a reduction (p < 0.001) in the
presence of 312.5 μg/ml ﬂuconazole, both in RPMI and RPMI
acetic acid, respectively.
Biofilm Formation of C. glabrata in the
Presence of Fluconazole
Considering that ADY2a and FPS1 were the most strongly
upregulated genes in acetate and given that FPS1 expression was
signiﬁcantly aﬀected by the presence of ﬂuconazole, we selected
these genes for further studies. The phenotype of ady2a and
fps1 C. glabrata mutant strains (Schwarzmuller et al., 2014) was
evaluated regarding their ability to grow in diﬀerent carbon
sources, at 30, 37, and 42◦C. The carbon sources tested included
glucose, glycerol, lactic, acetic, citric, malic, pyruvic, and succinic
acids. All mutant strains had a growth proﬁle identical to the wild
type (WT) strain in all carbon sources tested (data not shown).
Since acetate was used by the mutants as the only carbon and
energy source, we accessed bioﬁlm formation in the presence and
absence of acetate (Supplementary Figure S1). Notably, bioﬁlms
obtained for the mutants and for theWT strains were similar, and
all strains displayed increased bioﬁlm biomass in media without
acetic acid.
The eﬀect of ﬂuconazole was then tested in mutant bioﬁlms
in the presence and in the absence of acetic acid. For both
conditions, a statistically signiﬁcant reduction in bioﬁlm biomass
and in CFU count was observed with the highest concentration
of ﬂuconazole. This was a similar result to the one found for the
WT strain. Moreover, no statistically signiﬁcant diﬀerences were
observed between mutant and WT strains.
The Carbon Source Affects C. glabrata
Interaction with Phagocytic Cells
Since our data suggested that cells grown in media containing
acetic acid are more susceptible to ﬂuconazole, we evaluated how
macrophages interacted with C. glabrata cells previously grown
either in RPMI or RPMI with acetic acid.
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FIGURE 2 | Effect of acetic acid and fluconazole in the expression of ADY2a, ADY2b, FPS1, FPS2, and ATO3 in C. glabrata ATCC 2001 planktonic (A)
and biofilm cells (B). Cells and biofilms were grown in two different conditions: RPMI pH 5.0 and RPMI 0.5% acetic acid at pH 5.0. Legend displays fluconazole
concentrations used. Gene expression was calculated using CT method and normalized to PGK1 gene. Error bars represent SD. ∗ , ∗∗ , and ∗∗∗ means that results
are statistically significant (p < 0.05), (p < 0.01), and (p < 0.001), respectively.
To evaluate macrophage phagocytosis of C. glabrata cells
grown in the presence or absence of acetic acid, we used
a previously described assay (Carneiro et al., 2014). This
method allows the identiﬁcation of four diﬀerent macrophage
populations by diﬀerential staining, based on the distinct
interaction between macrophages and C. glabrata cells.
Therefore, macrophages with only internalized C. glabrata
cells (Sytox green-stained), with only surface adhered cells
(PI stained), with both internalized and surface adhered cells
(PI and Sytox green double stained) or with no contact with
C. glabrata cells (Sytox green and PI negative staining) were
clearly distinguished.
Representative ﬂuorescence microscopy and ﬂow cytometry
analyses are shown in Supplementary Figures S2 and S3.
In general, upon 30 min of co-incubation, ﬂow cytometry
analysis showed that a higher percentage of macrophages with
internalized yeast cells are present in comparison with the
percentage of macrophages with adherent or, adherent and
internalized yeast cells (Figure 3). Furthermore, C. glabrata
WT cells, previously adapted to acetic acid, resulted in 14.5%
of macrophages with internalized yeast cells which represents
twice of what was found when WT cells were grown only in
RPMI (7.6%, p < 0.001; Figure 3A). In addition, the percentage
of phagocytosis index was also signiﬁcantly higher (14.7%,
p < 0.001) in WT acetic acid-adapted cells in comparison with
C. glabrata cells grown without the acid (8.1%; Figure 3D).
We also assessed the capacity of macrophages to phagocytose
C. glabrata ady2a and fps1 mutant cells pre-grown in RPMI
with or without acetic acid. A clear diﬀerence between the
behavior of the diﬀerent mutants and the WT cells was found
(Figure 3).
Regarding fps1 mutant cells, no signiﬁcant diﬀerence in
the phagocytosis index was observed in cells grown in RPMI
in comparison with WT cells. Conversely, when adapted
to acetic acid a higher phagocytosis index for this mutant
was observed in comparison with the WT (p < 0.01;
Figure 3D). These results suggest that adaptation to acetic
acid renders fps1 mutant cells more susceptible to macrophage
phagocytosis.
This tendency was, however, not observed for ady2a mutant
yeast cells, as in RPMI medium they were more susceptible to
macrophage phagocytosis (p < 0.001), in comparison with the
WT. In addition, in this medium, ady2a mutation induced a
signiﬁcant lower percentage of macrophage adherent yeast cells
(p < 0.01, Figure 3B) and higher percentage of internalized
yeast cells (p < 0.001, Figure 3A). These results suggest that
ady2a mutation somehow enhances yeast cells recognition and
engulfment by macrophages.
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FIGURE 3 | Evaluation of phagocytosis of C. glabrata HTL, fps1, and ady2a cells by flow cytometry after 30 min of incubation at 37 ◦C with
macrophages. Before the phagocytosis assay yeast cells were grown in two different conditions: RPMI pH 5.0 and RPMI 0.5% acetic acid at pH 5.0. Graph
(A) represents the percentage of macrophages with yeast cells internalized, (B) shows the percentage of macrophages with yeast cells adhered to their
surface, (C) corresponds to the percentage of macrophages with yeast cells internalized and adhered, and (D) displays the percentage of phagocytosis,
resulting from the sum of (A) and (C). Error bars represent SD. ∗, ∗∗ , and ∗∗∗ means that results are statistically significant (p < 0.05), (p < 0.01), and
(p < 0.001), respectively.
The phagocytosis index of acetic acid adapted ady2a cells
was identical to the value found when cells were grown in sole
RPMI medium. This was in contrast to what was observed for
WT and fps1 mutant cells, which exhibit higher susceptibility
to macrophage recognition and engulfment, in RPMI acetic acid
medium (Figure 3).
To evaluate the eﬀect of acetic acid adaptation on phagocyte
interaction, macrophages were infected with C. glabrata,
previously grown in the presence or absence of acetic acid,
and yeast killing was assessed by CFU after 3 and 18 h of co-
incubation. Additionally, TNF-α was quantiﬁed to evaluate the
ability to induce a pro-inﬂammatory response. Results showed
that the percentage of C. glabrataWT killed by macrophages was
higher when cells were previously grown in RPMI with acetic
acid in comparison with RMPI alone, in particularly after 3 h of
incubation (Figure 4A).
Regarding C. glabrata mutant strains, although no statistical
signiﬁcance was reached, both fps1 and ady2a cells appear
to be more susceptible to macrophage killing than WT cells,
when grown in RPMI media, in particularly at the early time
point (Figure 4A). However, for yeast cells grown in the
presence of acetic acid, fps1 mutant behaved similarly to WT
cells, while ady2a cells were more resistant to killing. The
percentage of killing did not change with longer incubation
periods but was signiﬁcantly lower than WT or fps1 strains, in
the presence of acetic acid, for ady2a (WT vs. ady2a, p < 0.05
and fps1 vs. ady2a, p < 0.001). All cells and conditions were
able to trigger pro-inﬂammatory responses, with signiﬁcant
diﬀerences in the amount of TNF-α released from 3 to 18 h
of incubation. The amount of this cytokine was similar in all
conditions.
Taken together, these results show that WT C. glabrata
cells, grown in the presence of acetic acid, are better
internalized and killed by macrophages and suggest that acetic
acid renders ady2a mutant more resistance to macrophage
killing.
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FIGURE 4 | Evaluation of the interaction of C. glabrata HTL, fps1, and ady2a cells with macrophages. (A) Percentage of C. glabrata killing by
macrophages evaluated by CFU and (B) the TNF-α concentration released by macrophages infected with C. glabrata strains in pg/ml, Ctl1 and Ctl2
corresponds to the macrophages control and incubated with LPS, respectively. The results were assessed at 3 and 18 h post-infection (white and grey bars,
respectively). Before the phagocytosis assay yeast cells were grown in two different conditions: RPMI pH 5.0 and RPMI 0.5% acetic acid at pH 5.0. Error
bars represent SD. ∗, ∗∗, and ∗∗∗ means that results are statistically significant (p < 0.05), (p < 0.01), and (p < 0.001), respectively, when comparing 3 with
18 h of incubation. Other comparisons are indicated by a bar.
Discussion
Candida glabrata has the ability to survive within diﬀerent
host niches, with diverse nutrient availability. In such niches,
for example inside phagosomes, it faces glucose-limited
environments. To survive, it has to change its metabolism
and utilize non-fermentable carbon sources (Kaur et al., 2007;
Roetzer et al., 2010; Fukuda et al., 2013). In the intestine, where
glucose is scarce, C. glabrata requires Cyb2 for adaptation
and survival (Ueno et al., 2011). This protein is required
for the assimilation of lactate, a non-fermentable carbon
source present in the intestine (Ueno et al., 2011). Other
weak organic acids besides lactate are present in the intestine,
namely acetate, which can be produced by intestinal microbiota
(Yamaguchi et al., 2005). Moreover, this carboxylic acid is also
present in other human niches, including the vaginal mucosa
(Preti et al., 1979) and vaginal secretions (Huggins and Preti,
1976).
Ene et al. (2012a) showed that C. albicans cells grown in
an alternative carbon source, lactic acid, were more resistant to
amphotericin B but more susceptible to miconazole. Another
study reported that acetic acid, other alternative carbon
source, acted synergistically with clotrimazole and ﬂucytosine
in C. glabrata (Costa et al., 2013). In the present work, we
show that acetic acid increases susceptibility to ﬂuconazole in
planktonic cells (Table 3). This ﬁnding has an important clinical
impact, namely in the treatment of vaginal candidiasis, since
this niche has an acidic pH and is rich in alternative carbon
sources, such as lactic and acetic acid. In fact, Moosa et al.
(2004) showed that ﬂuconazole was fungicidal for C. albicans
in a synthetic vagina-simulative medium with an acidic pH.
The analysis of the components of the medium indicated
that acetic acid was responsible for the synergistic, fungicidal
eﬀect (Moosa et al., 2004). This study also reported that two
independent clinical isolates of C. glabrata were not killed
when grown in YNB medium supplemented with acetic acid
and ﬂuconazole, contrary to what was observed for C. albicans
strains (Moosa et al., 2004). By contrast, our work shows that
the synergistic eﬀect observed for C. albicans is also seen in
C. glabrata.
The present work demonstrates that C. glabrata forms
bioﬁlms in media containing acetic acid (RPMI 0.5% acetic
acid pH 5.0). However, in this media the bioﬁlm is weaker in
terms of total biomass and CFU when comparing to bioﬁlms
formed in the absence of acetate (Figure 1). In addition,
we studied the eﬀect of ﬂuconazole in C. glabrata pre-grown
bioﬁlms in the presence and in the absence of acetic acid.
Our results show that a statistically signiﬁcant reduction in
bioﬁlm biomass and in CFU count is obtained only to the
highest concentration of ﬂuconazole, for both tested conditions
(Supplementary Figure S1). These results are consistent with
reports for C. albicans bioﬁlms (Baillie and Douglas, 1998;
Chandra et al., 2001a,b; Ramage et al., 2001), showing that
bioﬁlms needed about 10 to 100 times more quantity of
antifungal drug to be eradicated when compared to planktonic
cells.
Host defenses against C. albicans infection are characterized
by a dynamic relationship between the activation of immune
responses and the capacity of the pathogen to modulate
these responses. The ﬁrst step in the activation of the host
immunity involves the recognition of several PAMPs exhibited
by pathogen. Many receptors recognize components of the
fungal cell wall leading to the phagocytosis of the fungal
cell (Netea and Marodi, 2010; Gow et al., 2012). Recently, it
has been described that C. albicans grown in the presence
of lactic acid can resist to phagocytosis better than when
grown in glucose (Ene et al., 2013). This work reported that
lactate grown C. albicans cells were more eﬃcient at killing
and escaping from macrophages (Ene et al., 2013). Given the
major impact of carbon source on C. albicans cell surface
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observed in some studies (Ene et al., 2012a,b), the diﬀerences
reported in terms of phagocytosis may reﬂect these alterations
in cells surface, where PAMPs are present. Therefore, we
analyzed the interaction of macrophages and C. glabrata cells
grown in two diﬀerent conditions: RPMI and RPMI with
acetic acid. We show that acetate-grown C. glabrata cells are
better phagocytosed than cells grown in glucose (Figure 3).
Moreover, after 3 h of post-infection, a higher percentage of
C. glabrata’ killing is observed when cells are grown in acetic
acid medium than when they are grown in glucose sole medium
(Figure 4). The presence of acetic acid is not an advantage
for fungal cells to deal with macrophages defense, which is
in contrast with other reports for C. albicans cells grown
in the presence of lactic acid. Future studies will compare
the eﬀects of lactate and acetate on C. glabrata cells and
examine the basis for the diﬀerent eﬀects of these carboxylic
acids.
We show that in both suspended cells and bioﬁlm structures,
ADY2a, ADY2b, FPS1, and ATO3 genes are more expressed in
the presence of acetic acid (Figure 2). These results support the
notion that these genes may be involved in acetic acid utilization
of this carbon-source. We also observed that ADY2a and FPS1
are the most highly upregulated genes under all the conditions
tested (Figure 2). The expression of these genes seems to vary
according to the concentration of ﬂuconazole. In RPMI bioﬁlm
cells with or without acetic acid, FPS1 expression highly increases
up to 312.5 μg/ml ﬂuconazole. A high ﬂuconazole concentration
however leads to a basal level of expression for all genes, both
in the presence and absence of acetic acid, although viable cells
are still found in these conditions. These genes seem to be
involved in the diﬀerential response of cells both to acetic acid
and ﬂuconazole.
In S. cerevisiae acetic acid can serve as an alternative carbon
source to fuel gluconeogenesis via the glyoxylate cycle (Turcotte
et al., 2010). As previously mentioned, some studies have
recognized the signiﬁcance of the glyoxylate cycle in the virulence
of C. albicans (Ramirez and Lorenz, 2007) and C. glabrata (Kaur
et al., 2007; Fukuda et al., 2013) and have shown that ADY2 and
FPS1 are expressed inside macrophages (Kaur et al., 2007; Seider
et al., 2011).
The phagocytosis assays here reported (Figure 3) reveal that
macrophages are able to recognize/internalize more eﬃciently
fps1 and ady2a cells thanWT cells, when cells are grown in RPMI,
indicating that mutant’s cell walls may present some alterations
that render themmore easily recognized. Beese-Sims et al. (2012)
demonstrated that fps1 was more susceptible to caspofungin, an
antifungal agent that targets cell wall glucans. However, in this
work we show that fps1 and WT acetic acid grown cells are more
easily recognized/internalized than cells grown in media without
the acid. In contrast, the presence of the acid does not aﬀect
the interaction of ady2a cells with the phagocytes. This suggests
that acetic acid does not induce a signiﬁcant alteration in the cell
wall of ady2a cells in contrast to what happens in fps1 and WT
cells.
Macrophages are important cells for pathogens’ elimination,
as well as immune modulators, presenting antigens and secreting
pro-inﬂammatory cytokines. In this sense we evaluated the
macrophages killing of the diﬀerent C. glabrata cells grown in
RPMI with or without acetic acid (Figure 4). No signiﬁcant
diﬀerences are observed in the amount of TNF-α released after
incubation, indicating that all cells and conditions are able to
similarly activate a pro-inﬂammatory response. Macrophages
are able to kill fps1 and ady2a mutants more eﬃciently
than WT ones (Figure 4). However, in cells grown in
RPMI and acetic acid, ady2a cells are much more refractory
to killing when compared to WT cells. Of note, previous
studies reported an ADY2a upregulation in C. glabrata cells
upon macrophage phagocytosis (Kaur et al., 2007; Seider
et al., 2011). In this work, when ady2a cells are grown in
RPMI medium, they are more eﬃciently internalized and
phagocytized by macrophages than WT cells. Additionally,
when grown in the presence of acetic acid they are more
resistant to macrophage killing than WT cells. This suggests
a potential role of Ady2a in phagocytosis and reveals that the
carbon source clearly aﬀects the cells response to macrophage
killing.
Conclusion
This study shows that acetic acid inﬂuences C. glabrata
behavior in bioﬁlm formation, antifungal drug resistance and
phagocytosis. It also suggests that Fps1 and Ady2a might play
a role in these processes. Our data support the view that
adaptative responses of Candida cells to the types of carbon
source present in host niches aﬀects the virulence of these
fungal cells through multifarious mechanisms (Brown et al.,
2014).
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